Notably, methyltransferase METTL14 and demethylase RBM10 were identified as significantly mutated genes (SMGs) in CCA, particularly with multiple high-frequency non-synonymous mutations observed in pCCA, leading to functional loss of the genes [62–64]. This evidence concerns the gene METTL14 and cholangiocarcinoma.